Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 21 clinical trials
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors

09/26/2018) Perivascular epithelioid cell tumor (PEComa) Apocrine tumors/extramammary Paget's disease (closed to accrual) Peritoneal mesothelioma Basal cell

neuroendocrine carcinoma
vasectomy
immunosuppressive
mullerian mixed tumor
squamous cell carcinoma
  • 6651 views
  • 22 Oct, 2022
  • 752 locations
Treatment of Malignant Peritoneal Mesothelioma (MESOTIP)

MESOTIP is a randomized trial evaluating the association of PIPAC and systemic chemotherapy versus systemic chemotherapy alone as 1st-line treatment of Malignant Peritoneal Mesothelioma In this

peritoneal mesothelioma
systemic chemotherapy
pressurized intraperitoneal aerosol chemotherapy
cytoreductive surgery
pemetrexed
  • 129 views
  • 14 Nov, 2021
  • 1 location
Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma

For cancers, such as mesothelioma, that spread to the lining of the stomach, detecting the cancer is very difficult with CT or MRI scans. Researchers at the University of Chicago want to find out if the new experimental MRI and ultrasound imaging techniques do a better job of detecting these …

peritoneal mesothelioma
cancer
  • 2 views
  • 27 May, 2022
  • 1 location
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

This phase II trial compares the usual treatment alone to using immunotherapy (atezolizumab) plus the usual treatment in treating patients with peritoneal mesothelioma. The usual treatment

  • 0 views
  • 07 Oct, 2022
  • 20 locations
Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma (INTERACT MESO)

Patients primary malignant peritoneal mesothelioma (MPM), without extra-abdominal disease, that are not eligible (or willing) to undergo cytoreductive surgery (CRS) with hyperthermic

  • 0 views
  • 04 Oct, 2022
  • 1 location
A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma

This study is for individuals who have peritoneal mesothelioma, a cancer of the lining of your abdominal wall and organs (the peritoneum). Doctors leading the study would like to determine the

chemotherapy regimen
peritoneal mesothelioma
cancer
  • 0 views
  • 16 Mar, 2022
  • 1 location
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies

Background Cytoreductive surgery (CRS) removes tumors in the abdomen. HIPEC is heated chemotherapy that washes the abdomen. CRS and HIPEC may help people with peritoneal carcinomatosis. These are tumors that have spread to the lining of the abdomen from other cancers. Researchers think they can improve results of CRS and …

neutrophil count
antineoplastic
5-fluorouracil
mitomycin
cancer chemotherapy
  • 0 views
  • 28 Oct, 2022
  • 1 location
  • 2 views
  • 26 Sep, 2021
  • 2 locations
CAR T Cells in Mesothelin Expressing Cancers

Phase I study to establish safety and feasibility of both intravenous administration and local delivery of lentiviral transduced huCART-meso cells with or without lymphodepletion.

cyclophosphamide
cns metastases
peritoneal carcinoma
peritoneal mesothelioma
pericardial effusion
  • 74 views
  • 03 Feb, 2022
  • 1 location
Phase I Study of Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma

. Eligibility Adults ages 18 and older with malignant pleural or peritoneal mesothelioma that cannot be cured with surgery and has not responded to standard first

neutrophil count
urine test
peritoneal mesothelioma
aptt
measurable disease
  • 0 views
  • 21 Oct, 2022
  • 1 location